The COVVI-19 pandemic allowed the advent of a revolutionary technology: Messenger RNA vaccines (mRNA), which entered the market during the health crisis. The researchers managed to develop their vaccines in less than a year, reversing the pandemic course and spraying the record reached with the mirror vaccine, developed in four years.
In addition to the millions of saved lives, this breakthrough has confirmed the revolutionary therapeutic mRNA potential, and several hundred clinical trials are currently underway. “This technology is just starting to arrive on the market,” observes Mirella Salvatore, from the Faculty of Medicine of Cornell University, in New York.
If most of us have discovered the existence of this type of vaccines thanks to the pandemic, the history of their development has, in fact, started over fifty years ago.
In 1961, researchers identified mRNA and its role in supporting information, which allows protein synthesis in cells. This discovery opens a tremendous perspective: that of using this molecule to push our cells to produce proteins, without any other prerequisite than decryption of
The rest is reserved for subscribers …
Source of the article
New Scientist (Londres)
Stimulating, concerned with ecology and good popularizer, New Scientist is one of the best scientific information magazines in the world. Created in 1956, he made a third of his sales abroad.
He is particularly interested in scientific and technological developments …
